Medical Equipment

Lipid Panel Testing Market Analysis With Focus On Growth Potential And Future Outlook

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Lipid Panel Testing Market Between 2026 And 2030?

The lipid panel testing market has experienced significant growth in recent years. It is anticipated to expand from $11.61 billion in 2025 to $12.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. The historical expansion of this market can be attributed to the rising occurrence of cardiovascular diseases, the wider implementation of routine health screening initiatives, increased public understanding of cholesterol management, the uptake of automated laboratory diagnostics, and better access to diagnostic services.

The lipid panel testing market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $17.79 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is fueled by an increasing emphasis on preventive healthcare, a rise in demand for home diagnostics, the integration of digital health platforms, the growing application of AI-assisted diagnostic interpretation, and the expansion of population health screening initiatives. Prominent trends for the forecast period include the rising adoption of point-of-care lipid testing, increased utilization of automated lipid analyzers, a growing need for preventive cardiovascular screening, the proliferation of home-based lipid testing kits, and an elevated focus on early risk assessment.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

What Key Factors Are Shaping The Lipid Panel Testing Market Landscape?

The increasing occurrence of cardiovascular and diabetic diseases is anticipated to propel the growth of the lipid panel testing market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, while diabetes is a chronic metabolic condition characterized by elevated blood glucose levels. Both conditions significantly heighten the risk of lipid abnormalities, making lipid testing essential for early detection, risk stratification, treatment planning, and long-term monitoring. Lipid panel testing helps clinicians identify dyslipidemia, guide therapeutic interventions, and reduce the risk of complications such as heart attack and stroke. For instance, in September 2025, according to the American College of Cardiology (ACC), a US-based nonprofit medical association, global cardiovascular disease deaths reached $ 0.0192 billion (19.2 million) in 2023. Consequently, the rising burden of cardiovascular and diabetic diseases is driving the growth of the lipid panel testing market.

Which Segments Define The Lipid Panel Testing Market Segment Structure?

The lipid panel testing market covered in this report is segmented –

1) By Product And Services: Devices, Kits, Services

2) By Prescription Mode: Prescription-Based Testing, OTC-Based Testing

3) By Application: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hypo-Lipoproteinemia, Tangier Disease, Atherosclerosis, Other Applications

4) By End User: Hospital, Specialty Clinics And Physician Offices, Pathology Laboratories, Diagnostic Clinics, Reference Laboratories, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Devices: Automated Analyzers, Point-Of-Care Testing Devices, Spectrophotometers

2) By Kits: Test Kits For Cholesterol, HDL And LDL Kits, Triglyceride Test Kits

3) By Services: Laboratory Testing Services, Diagnostic Services, Health Screening Services

What Market Trends Are Affecting The Lipid Panel Testing Market?

Leading entities within the lipid panel testing market are concentrating on creating sophisticated solutions, including Lp(a)-based diagnostic assays, to improve the evaluation of cardiovascular risk. Specifically, an Lp(a)-based assay is a medical examination designed to quantify lipoprotein(a) levels in blood, allowing healthcare providers to pinpoint individuals with increased susceptibility to cardiovascular conditions and offer customized therapeutic advice. As an illustration, in May 2024, F. Hoffmann-La Roche AG, a biotechnology and diagnostics firm headquartered in Switzerland, introduced the Tina-quant Lp(a) RxDx assay, having secured FDA Breakthrough Device Designation. This novel product assesses the concentration of Lp(a) molecules per litre in an individual’s bloodstream, thereby furnishing a consistent and practical biomarker for evaluating cardiovascular risk. Its integration into Roche’s existing serum work area (SWA) systems and cobas® platforms empowers healthcare professionals to make well-informed choices concerning Lp(a)-lowering treatments, leading to better patient outcomes and fostering precise cardiovascular care. The assay streamlines Lp(a) analysis, enhances diagnostic precision, and facilitates broader implementation of individualized lipid management approaches.

Who Are The Established Players Within The Lipid Panel Testing Market?

Major companies operating in the lipid panel testing market are Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics LLC

Get The Full Lipid Panel Testing Market Report:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Which Region Accounts For The Largest Portion Of The Lipid Panel Testing Market?

North America was the largest region in the lipid panel testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lipid Panel Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Browse Through More Reports Similar to the Global Lipid Panel Testing Market 2026, By The Business Research Company

Lipid Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Lipid Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Lipid Regulators Market Report 2026

https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795